Posted by Peatness on April 23, 2006, at 10:44:16
Hello. I am currently participating in a phase three trial of Licarbazapine for bipolar disorder. I am still currently in the double-blind portion of the study (six weeks in total)and I am interested in hearing from anyone who has completed the full study (12 months on the active drug). I would also like to know whether any participants have been granted use of the medication by Novartis when the study concluded (referred to as compasionate use, or something along those lines). I look forward to your feedback.
Peat
poster:Peatness
thread:636142
URL: http://www.dr-bob.org/babble/20060423/msgs/636142.html